My Bibliography

select

Wang J, Li H, Kulkarni A, Anderson JL, Upadhyay P, Onyekachi OV, Arantes LMRB, Banerjee H, Kane LP, Zhang X, Bruno TC, Bao R, Ferris RL, Vujanovic L. Differential impact of TIM-3 ligands on NK cell function. J Immunother Cancer. 2025 Jan 7;13(1). doi: 10.1136/jitc-2024-010618. PubMed PMID: 39773563; PubMed Central PMCID: PMC11748930.

select

Chawla P, Sharma I, Gau D, Eder I, Chen F, Yu V, Welling N, Boone D, Taboas J, Lee AV, Larregina A, Galson DL, Roy P. Breast cancer cells promote osteoclast differentiation in an MRTF-dependent paracrine manner. Mol Biol Cell. 2025 Jan 1;36(1):ar8. doi: 10.1091/mbc.E24-06-0285. Epub 2024 Dec 4. PubMed PMID: 39630611; PubMed Central PMCID: PMC11742114.

select

Lee S, Cho Y, Li Y, Li R, Lau AW, Laird MS, Brown D, McAuliffe P, Lee AV, Oesterreich S, Zervantonakis IK, Osmanbeyoglu HU. Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer. Oncoimmunology. 2024 Dec 31;13(1):2429186. doi: 10.1080/2162402X.2024.2429186. Epub 2024 Nov 26. PubMed PMID: 39587886; PubMed Central PMCID: PMC11601052.

select

Li Z, Chen F, Chen L, Liu J, Tseng D, Hadi F, Omarjee S, Kishore K, Kent J, Kirkpatrick J, D'Santos C, Lawson M, Gertz J, Sikora MJ, McDonnell DP, Carroll JS, Polyak K, Oesterreich S, Lee AV. The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer. NPJ Breast Cancer. 2024 Dec 19;10(1):106. doi: 10.1038/s41523-024-00709-4. PubMed PMID: 39702552; PubMed Central PMCID: PMC11659402.

select

Zhang Y, Banihashemi L, Versace A, Samolyk A, Taylor M, English G, Schmithorst VJ, Lee VK, Stiffler R, Aslam H, Panigrahy A, Hipwell AE, Phillips ML. Early Infant Prefrontal Cortical Microstructure Predicts Present and Future Emotionality. Biol Psychiatry. 2024 Dec 15;96(12):959-970. doi: 10.1016/j.biopsych.2024.04.001. Epub 2024 Apr 9. PubMed PMID: 38604525; PubMed Central PMCID: PMC11461701.

select

Chen F, Onkar S, Zou J, Li Y, Arbore H, Maley S, Tseng G, Lucas PC, Bruno TC, Vignali DAA, Foldi J, Balic M, Lee AV, Oesterreich S. Immune infiltration correlates with transcriptomic subtypes in primary estrogen receptor positive invasive lobular breast cancer. NPJ Precis Oncol. 2024 Nov 9;8(1):257. doi: 10.1038/s41698-024-00746-z. PubMed PMID: 39521942; PubMed Central PMCID: PMC11550424.

select

Wang Y, Hu M, Finn OJ, Wang XS. Tumor-Associated Antigen Burden Correlates with Immune Checkpoint Blockade Benefit in Tumors with Low Levels of T-cell Exhaustion. Cancer Immunol Res. 2024 Nov 4;12(11):1589-1602. doi: 10.1158/2326-6066.CIR-23-0932. PubMed PMID: 39137006; PubMed Central PMCID: PMC11534523.

select

DePoy LM, Petersen KA, Zong W, Ketchesin KD, Matthaei RC, Yin R, Perez MS, Vadnie CA, Becker-Krail D, Scott MR, Tseng GC, McClung CA. Cell-type and sex-specific rhythmic gene expression in the nucleus accumbens. Mol Psychiatry. 2024 Oct;29(10):3117-3127. doi: 10.1038/s41380-024-02569-7. Epub 2024 Apr 27. PubMed PMID: 38678086; PubMed Central PMCID: PMC11449664.

select

Luo Z, Wan Z, Ren P, Zhang B, Huang Y, West RE 3rd, Huang H, Chen Y, Nolin TD, Xie W, Wang J, Li S, Sun J. In Situ Formation of Fibronectin-Enriched Protein Corona on Epigenetic Nanocarrier for Enhanced Synthetic Lethal Therapy. Adv Sci (Weinh). 2024 May;11(19):e2307940. doi: 10.1002/advs.202307940. Epub 2024 Mar 14. PubMed PMID: 38482976; PubMed Central PMCID: PMC11109615.

select

Wang LJ, Ning M, Nayak T, Kasper MJ, Monga SP, Huang Y, Chen Y, Chiu YC. shinyDeepDR: A user-friendly R Shiny app for predicting anti-cancer drug response using deep learning. Patterns (N Y). 2024 Feb 9;5(2):100894. doi: 10.1016/j.patter.2023.100894. eCollection 2024 Feb 9. PubMed PMID: 38370127; PubMed Central PMCID: PMC10873157.

select

Miranda O, Fan P, Qi X, Wang H, Brannock MD, Kosten T, Ryan ND, Kirisci L, Wang L. Prediction of adverse events risk in patients with comorbid post-traumatic stress disorder and alcohol use disorder using electronic medical records by deep learning models. Drug Alcohol Depend. 2024 Feb 1;255:111066. doi: 10.1016/j.drugalcdep.2023.111066. Epub 2024 Jan 9. PubMed PMID: 38217979; PubMed Central PMCID: PMC10853953.

select

Zou J, Shah O, Chiu YC, Ma T, Atkinson JM, Oesterreich S, Lee AV, Tseng GC. Systems approach for congruence and selection of cancer models towards precision medicine. PLoS Comput Biol. 2024 Jan;20(1):e1011754. doi: 10.1371/journal.pcbi.1011754. eCollection 2024 Jan. PubMed PMID: 38198519; PubMed Central PMCID: PMC10805322.

select

Shah OS, Chen F, Wedn A, Kashiparekh A, Knapick B, Chen J, Savariau L, Clifford B, Hooda J, Christgen M, Xavier J, Oesterreich S, Lee AV. Multi-omic characterization of ILC and ILC-like cell lines as part of ILC cell line encyclopedia (ICLE) defines new models to study potential biomarkers and explore therapeutic opportunities. bioRxiv. 2023 Dec 12;. doi: 10.1101/2023.09.26.559548. PubMed PMID: 37808708; PubMed Central PMCID: PMC10557671.

select

Hong L, Braden DC, Zhao Y, Skoko JJ, Chang F, Woodcock SR, Uvalle C, Casey A, Wood K, Salvatore SR, Asan A, Harkness T, Fagunloye A, Razzaghi M, Straub A, Spies M, Brown DD, Lee AV, Schopfer F, Freeman BA, Neumann CA. Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapies. Redox Biol. 2023 Oct;66:102856. doi: 10.1016/j.redox.2023.102856. Epub 2023 Aug 19. PubMed PMID: 37633047; PubMed Central PMCID: PMC10472314.

select

Yates ME, Li Z, Li Y, Guzolik H, Wang X, Liu T, Hooda J, Atkinson JM, Lee AV, Oesterreich S. ESR1 fusion proteins invoke breast cancer subtype-dependent enrichment of ligand independent pro-oncogenic signatures and phenotypes. bioRxiv. 2023 Sep 19;. doi: 10.1101/2023.09.18.558175. PubMed PMID: 37790296; PubMed Central PMCID: PMC10542116.

select

Elangovan A, Bossart EA, Basudan A, Tasdemir N, Shah OS, Ding K, Meier C, Heim T, Neumann C, Attaran S, Brown L, Hooda J, Miller L, Liu T, Puhalla SL, Gurda G, Lucas PC, McAuliffe PF, Atkinson JM, Lee AV, Oesterreich S. WCRC-25: A novel luminal Invasive Lobular Carcinoma cell line model. bioRxiv. 2023 Sep 17;. doi: 10.1101/2023.09.15.558023. PubMed PMID: 37745587; PubMed Central PMCID: PMC10516031.

select

Li Z, Li T, Yates ME, Wu Y, Ferber A, Chen L, Brown DD, Carroll JS, Sikora MJ, Tseng GC, Oesterreich S, Lee AV. The EstroGene Database Reveals Diverse Temporal, Context-Dependent, and Bidirectional Estrogen Receptor Regulomes in Breast Cancer. Cancer Res. 2023 Aug 15;83(16):2656-2674. doi: 10.1158/0008-5472.CAN-23-0539. PubMed PMID: 37272757; PubMed Central PMCID: PMC10527051.

select

Hong L, Braden DC, Zhao Y, Skoko JJ, Chang F, Woodcock SR, Uvalle C, Casey A, Wood K, Salvatore SR, Asan A, Harkness T, Fagunloye A, Razzaghi M, Straub A, Spies M, Brown DD, Lee AV, Schopfer F, Freeman BA, Neumann CA. Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapies. bioRxiv. 2023 Aug 14;. doi: 10.1101/2023.08.11.552990. PubMed PMID: 37645906; PubMed Central PMCID: PMC10462009.

select

Das A, Meng W, Liu Z, Hasib MM, Galloway H, Ramos da Silva S, Chen L, Sica GL, Paniz-Mondolfi A, Bryce C, Grimes Z, Sordillo EM, Cordon-Cardo C, Rivera KP, Flores M, Chiu YC, Huang Y, Gao SJ. Molecular and immune signatures, and pathological trajectories of fatal COVID-19 lungs defined by in situ spatial single-cell transcriptome analysis. J Med Virol. 2023 Aug;95(8):e29009. doi: 10.1002/jmv.29009. PubMed PMID: 37563850; PubMed Central PMCID: PMC10442191.

select

Yu J, da Silva EM, La HS, Clark BZ, Fine JL, Carter GJ, Villatoro TM, Soong TR, Lee AV, Oesterreich S, Basili T, Blanco-Heredia J, Selenica P, Ye Q, Da Cruz Paula A, Dopeso H, Gazzo A, Marra A, Pareja F, Reis-Filho JS, Bhargava R. Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?. NPJ Breast Cancer. 2023 Jul 13;9(1):60. doi: 10.1038/s41523-023-00566-7. PubMed PMID: 37443169; PubMed Central PMCID: PMC10345141.

select

Onkar S, Cui J, Zou J, Cardello C, Cillo AR, Uddin MR, Sagan A, Joy M, Osmanbeyoglu HU, Pogue-Geile KL, McAuliffe PF, Lucas PC, Tseng GC, Lee AV, Bruno TC, Oesterreich S, Vignali DAA. Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment. Nat Cancer. 2023 Apr;4(4):516-534. doi: 10.1038/s43018-023-00527-w. Epub 2023 Mar 16. PubMed PMID: 36927792; PubMed Central PMCID: PMC11194444.

select

Zong W, Rahman T, Zhu L, Zeng X, Zhang Y, Zou J, Liu S, Ren Z, Li JJ, Sibille E, Lee AV, Oesterreich S, Ma T, Tseng GC. Transcriptomic congruence analysis for evaluating model organisms. Proc Natl Acad Sci U S A. 2023 Feb 7;120(6):e2202584120. doi: 10.1073/pnas.2202584120. Epub 2023 Feb 2. PubMed PMID: 36730203; PubMed Central PMCID: PMC9963430.

select

Li Z, Li T, Yates ME, Wu Y, Ferber A, Chen L, Brown DD, Carroll JS, Sikora MJ, Tseng GC, Oesterreich S, Lee AV. EstroGene database reveals diverse temporal, context-dependent and directional estrogen receptor regulomes in breast cancer. bioRxiv. 2023 Feb 2;. doi: 10.1101/2023.01.30.526388. PubMed PMID: 36778377; PubMed Central PMCID: PMC9915613.

select

Onkar SS, Carleton NM, Lucas PC, Bruno TC, Lee AV, Vignali DAA, Oesterreich S. The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes. Cancer Discov. 2023 Jan 9;13(1):23-40. doi: 10.1158/2159-8290.CD-22-0475. Review. PubMed PMID: 36620880; PubMed Central PMCID: PMC9833841.

select

Fan P, Kofler J, Ding Y, Marks M, Sweet RA, Wang L. Efficacy difference of antipsychotics in Alzheimer's disease and schizophrenia: explained with network efficiency and pathway analysis methods. Brief Bioinform. 2022 Nov 19;23(6). doi: 10.1093/bib/bbac394. PubMed PMID: 36151774; PubMed Central PMCID: PMC9677501.

select

Ding K, Chen F, Priedigkeit N, Brown DD, Weiss K, Watters R, Levine KM, Heim T, Li W, Hooda J, Lucas PC, Atkinson JM, Oesterreich S, Lee AV. Single cell heterogeneity and evolution of breast cancer bone metastasis and organoids reveals therapeutic targets for precision medicine. Ann Oncol. 2022 Oct;33(10):1085-1088. doi: 10.1016/j.annonc.2022.06.005. Epub 2022 Jun 25. PubMed PMID: 35764274; PubMed Central PMCID: PMC10007959.

select

Elangovan A, Hooda J, Savariau L, Puthanmadhomnarayanan S, Yates ME, Chen J, Brown DD, McAuliffe PF, Oesterreich S, Atkinson JM, Lee AV. Loss of E-cadherin Induces IGF1R Activation and Reveals a Targetable Pathway in Invasive Lobular Breast Carcinoma. Mol Cancer Res. 2022 Sep 2;20(9):1405-1419. doi: 10.1158/1541-7786.MCR-22-0090. PubMed PMID: 35665642; PubMed Central PMCID: PMC9444924.

select

Loo SK, Yates ME, Yang S, Oesterreich S, Lee AV, Wang XS. Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance. Genes Chromosomes Cancer. 2022 May;61(5):261-273. doi: 10.1002/gcc.23029. Epub 2022 Feb 17. Review. PubMed PMID: 35106856; PubMed Central PMCID: PMC8930468.

select

Li Z, Wu Y, Yates ME, Tasdemir N, Bahreini A, Chen J, Levine KM, Priedigkeit NM, Nasrazadani A, Ali S, Buluwela L, Arnesen S, Gertz J, Richer JK, Troness B, El-Ashry D, Zhang Q, Gerratana L, Zhang Y, Cristofanilli M, Montanez MA, Sundd P, Wallace CT, Watkins SC, Fumagalli C, Guerini-Rocco E, Zhu L, Tseng GC, Wagle N, Carroll JS, Jank P, Denkert C, Karsten MM, Blohmer JU, Park BH, Lucas PC, Atkinson JM, Lee AV, Oesterreich S. Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis. Cancer Res. 2022 Apr 1;82(7):1321-1339. doi: 10.1158/0008-5472.CAN-21-2576. PubMed PMID: 35078818; PubMed Central PMCID: PMC8983597.

select

Miranda O, Fan P, Qi X, Yu Z, Ying J, Wang H, Brent DA, Silverstein JC, Chen Y, Wang L. DeepBiomarker: Identifying Important Lab Tests from Electronic Medical Records for the Prediction of Suicide-Related Events among PTSD Patients. J Pers Med. 2022 Mar 24;12(4). doi: 10.3390/jpm12040524. PubMed PMID: 35455640; PubMed Central PMCID: PMC9025406.

select

Lee JL, Ekambaram P, Carleton NM, Hu D, Klei LR, Cai Z, Myers MI, Hubel NE, Covic L, Agnihotri S, Krappmann D, Bornancin F, Lee AV, Oesterreich S, McAllister-Lucas LM, Lucas PC. MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast Cancer. Mol Cancer Res. 2022 Mar 1;20(3):373-386. doi: 10.1158/1541-7786.MCR-21-0208. PubMed PMID: 34753803; PubMed Central PMCID: PMC8898271.

select

Cosgrove N, Varešlija D, Keelan S, Elangovan A, Atkinson JM, Cocchiglia S, Bane FT, Singh V, Furney S, Hu C, Carter JM, Hart SN, Yadav S, Goetz MP, Hill ADK, Oesterreich S, Lee AV, Couch FJ, Young LS. Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities. Nat Commun. 2022 Jan 26;13(1):514. doi: 10.1038/s41467-022-27987-5. PubMed PMID: 35082299; PubMed Central PMCID: PMC8791982.

select

Carleton N, Nasrazadani A, Gade K, Beriwal S, Barry PN, Brufsky AM, Bhargava R, Berg WA, Zuley ML, van Londen GJ, Marroquin OC, Thull DL, Mai PL, Diego EJ, Lotze MT, Oesterreich S, McAuliffe PF, Lee AV. Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women. Lancet Healthy Longev. 2022 Jan;3(1):e54-e66. doi: 10.1016/s2666-7568(21)00280-4. Epub 2022 Jan 5. Review. PubMed PMID: 35047868; PubMed Central PMCID: PMC8765742.

select

Gou X, Anurag M, Lei JT, Kim BJ, Singh P, Seker S, Fandino D, Han A, Rehman S, Hu J, Korchina V, Doddapaneni H, Dobrolecki LE, Mitsiades N, Lewis MT, Welm AL, Li S, Lee AV, Robinson DR, Foulds CE, Ellis MJ. Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer. Cancer Res. 2021 Dec 15;81(24):6259-6272. doi: 10.1158/0008-5472.CAN-21-1256. Epub 2021 Oct 28. PubMed PMID: 34711608; PubMed Central PMCID: PMC9234971.

select

Rosenzweig M, Miller LA, Lee AV, Oesterreich S, Trejo Bittar HE, Atkinson JM, Welsh A. The Development and Implementation of an Autopsy/ Tissue Donation for Breast Cancer Research. New Bioeth. 2021 Dec;27(4):349-361. doi: 10.1080/20502877.2021.1993608. Epub 2021 Nov 19. PubMed PMID: 34797208.

select

Sflomos G, Schipper K, Koorman T, Fitzpatrick A, Oesterreich S, Lee AV, Jonkers J, Brunton VG, Christgen M, Isacke C, Derksen PWB, Brisken C. Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions. Cancers (Basel). 2021 Oct 27;13(21). doi: 10.3390/cancers13215396. Review. PubMed PMID: 34771558; PubMed Central PMCID: PMC8582475.

select

Mohammad Mirzaei N, Su S, Sofia D, Hegarty M, Abdel-Rahman MH, Asadpoure A, Cebulla CM, Chang YH, Hao W, Jackson PR, Lee AV, Stover DG, Tatarova Z, Zervantonakis IK, Shahriyari L. A Mathematical Model of Breast Tumor Progression Based on Immune Infiltration. J Pers Med. 2021 Oct 15;11(10). doi: 10.3390/jpm11101031. PubMed PMID: 34683171; PubMed Central PMCID: PMC8540934.

select

Hankins ML, Smith CN, Hersh B, Heim T, Belayneh R, Dooley S, Lee AV, Oesterreich S, Lucas PC, Puhalla SL, Weiss KR, Watters RJ. Prognostic factors and survival of patients undergoing surgical intervention for breast cancer bone metastases. J Bone Oncol. 2021 Aug;29:100363. doi: 10.1016/j.jbo.2021.100363. eCollection 2021 Aug. PubMed PMID: 34040953; PubMed Central PMCID: PMC8143999.

select

Watters RJ, Verdelis K, Lucas PC, Jiang S, Chen Y, Lu F, Martin BM, Lukashova L, Pecar G, Morales-Restrepo A, Hankins M, Zhu L, Mittwede P, Hartmaier RJ, Alexander PG, Tseng GC, Weiss KR, Galson DL, Lee AV, Lee B, Oesterreich S. A Novel Mouse Model for SNP in Steroid Receptor Co-Activator-1 Reveals Role in Bone Density and Breast Cancer Metastasis. Endocrinology. 2021 Aug 1;162(8). doi: 10.1210/endocr/bqab094. PubMed PMID: 33963375; PubMed Central PMCID: PMC8248588.

select

Erdem C, Lee AV, Taylor DL, Lezon TR. Inhibition of RPS6K reveals context-dependent Akt activity in luminal breast cancer cells. PLoS Comput Biol. 2021 Jun;17(6):e1009125. doi: 10.1371/journal.pcbi.1009125. eCollection 2021 Jun. PubMed PMID: 34191793; PubMed Central PMCID: PMC8277016.

select

Sannino S, Yates ME, Schurdak ME, Oesterreich S, Lee AV, Wipf P, Brodsky JL. Unique integrated stress response sensors regulate cancer cell susceptibility when Hsp70 activity is compromised. Elife. 2021 Jun 28;10. doi: 10.7554/eLife.64977. PubMed PMID: 34180400; PubMed Central PMCID: PMC8275131.

select

Liu T, Hooda J, Atkinson JM, Whiteside TL, Oesterreich S, Lee AV. Exosomes in Breast Cancer - Mechanisms of Action and Clinical Potential. Mol Cancer Res. 2021 Jun;19(6):935-945. doi: 10.1158/1541-7786.MCR-20-0952. Epub 2021 Feb 24. Review. PubMed PMID: 33627501; PubMed Central PMCID: PMC8178200.

select

Shah OS, Soran A, Sahin M, Knapick BA, Ugras S, Celik E, Lucas PC, Lee AV. Identifying Genomic Alterations in Patients With Stage IV Breast Cancer Using MammaSeq: An International Collaborative Study. Clin Breast Cancer. 2021 Jun;21(3):210-217. doi: 10.1016/j.clbc.2020.08.009. Epub 2020 Aug 20. PubMed PMID: 33191115; PubMed Central PMCID: PMC11572555.

select

Carleton N, Zou J, Fang Y, Koscumb SE, Shah OS, Chen F, Beriwal S, Diego EJ, Brufsky AM, Oesterreich S, Shapiro SD, Ferris R, Emens LA, Tseng G, Marroquin OC, Lee AV, McAuliffe PF. Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer. JAMA Netw Open. 2021 Apr 1;4(4):e216322. doi: 10.1001/jamanetworkopen.2021.6322. PubMed PMID: 33856473; PubMed Central PMCID: PMC8050744.

select

Varešlija D, Ward E, Purcell SP, Cosgrove NS, Cocchiglia S, O'Halloran PJ, Charmsaz S, Bane FT, Brett FM, Farrell M, Cryan J, Beausang A, Hudson L, Turnbul AK, Dixon JM, Hill ADK, Priedigkeit N, Oesterreich S, Lee AV, Sims AH, Redmond AM, Carroll JS, Young LS. Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype. Oncogene. 2021 Feb;40(7):1318-1331. doi: 10.1038/s41388-020-01606-3. Epub 2021 Jan 8. PubMed PMID: 33420368; PubMed Central PMCID: PMC7892341.

select

Chen F, Ding K, Priedigkeit N, Elangovan A, Levine KM, Carleton N, Savariau L, Atkinson JM, Oesterreich S, Lee AV. Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells. Cancer Res. 2021 Jan 15;81(2):268-281. doi: 10.1158/0008-5472.CAN-20-0696. Epub 2020 Nov 4. PubMed PMID: 33148662; PubMed Central PMCID: PMC7856056.

select

Priedigkeit N, Ding K, Horne W, Kolls JK, Du T, Lucas PC, Blohmer JU, Denkert C, Machleidt A, Ingold-Heppner B, Oesterreich S, Lee AV. Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrences. Breast Cancer Res. 2021 Jan 6;23(1):1. doi: 10.1186/s13058-020-01379-3. PubMed PMID: 33407744; PubMed Central PMCID: PMC7788918.

select

Charmsaz S, Doherty B, Cocchiglia S, Varešlija D, Marino A, Cosgrove N, Marques R, Priedigkeit N, Purcell S, Bane F, Bolger J, Byrne C, O'Halloran PJ, Brett F, Sheehan K, Brennan K, Hopkins AM, Keelan S, Jagust P, Madden S, Martinelli C, Battaglini M, Oesterreich S, Lee AV, Ciofani G, Hill ADK, Young LS. ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis. BMC Med. 2020 Nov 19;18(1):349. doi: 10.1186/s12916-020-01806-4. PubMed PMID: 33208158; PubMed Central PMCID: PMC7677775.

select

Tao Y, Lei H, Lee AV, Ma J, Schwartz R. Neural Network Deconvolution Method for Resolving Pathway-Level Progression of Tumor Clonal Expression Programs With Application to Breast Cancer Brain Metastases. Front Physiol. 2020;11:1055. doi: 10.3389/fphys.2020.01055. eCollection 2020. PubMed PMID: 33013452; PubMed Central PMCID: PMC7499245.

select

Sreekumar S, Levine KM, Sikora MJ, Chen J, Tasdemir N, Carter D, Dabbs DJ, Meier C, Basudan A, Boone D, McAuliffe PF, Jankowitz RC, Lee AV, Atkinson JM, Oesterreich S. Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast Carcinoma. Endocrinology. 2020 Sep 1;161(9). doi: 10.1210/endocr/bqaa109. PubMed PMID: 32609836; PubMed Central PMCID: PMC7438704.